Biogen
BIIB
#917
Rank
โ‚ฌ19.98 B
Marketcap
136,51ย โ‚ฌ
Share price
2.50%
Change (1 day)
-31.61%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) Fails to deliver data

Key failure to deliver metrics for Biogen:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Biogen (BIIB) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Biogen (BIIB) - since 2013

Volume in USD (price x number of shares), data since 2013

Biogen (BIIB) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ20.65 M-71.27%
2024โ‚ฌ71.88 M27.44%
2023โ‚ฌ56.4 M-14.65%
2022โ‚ฌ66.08 M7.92%
2021โ‚ฌ61.24 M-56.04%
2020โ‚ฌ0.13 B67.82%
2019โ‚ฌ83.01 M-43.79%
2018โ‚ฌ0.14 B69.32%
2017โ‚ฌ87.22 M-29.4%
2016โ‚ฌ0.12 B-16.47%
2015โ‚ฌ0.14 B-18.15%
2014โ‚ฌ0.18 B579.65%
2013โ‚ฌ26.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ37.38 Mโ‚ฌ0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ28.08 Mโ‚ฌ96.29 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ43.04 Mโ‚ฌ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ24.22 Mโ‚ฌ0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.09 Mโ‚ฌ0.22 B๐Ÿ‡บ๐Ÿ‡ธ USA
N/Aโ‚ฌ0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.21 Mโ‚ฌ47.51 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ2.87 Mโ‚ฌ14.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.21 Mโ‚ฌ69.96 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.95 Mโ‚ฌ0.95 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands